More than 300 organizations sent letters to the White House and Congress on Tuesday asking them to extend telehealth controlled substance prescribing rules for an additional two years. They say the ...

BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS ...

For elements 7 and 8 above, the NPRM describes how the DEA may adopt one or both proposals. The appointment of a lead for the DEA by President-elect Donald Trump remains pending, leaving uncertainty ...